Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid tumors, having a large number of regulatory T (Treg) cells is linked to ...
Rucaparib maintenance therapy provided consistent benefits across all subgroups of patients grouped by prognostic factors of their homologous recombination deficiency-negative ovarian cancer tumors.
A recent Nature Aging study evaluates the effectiveness of a senolytic therapy based on chimeric antigen receptor (CAR) T-cells. In this therapy, senolytic CAR T-cells target urokinase plasminogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback